Beverley Isherwood,
Associate Director & Head High Content Biology, Innovative Medicines
Bev Isherwood is Associate Director of High Content Biology at AstraZeneca. Bev has global responsibility for the development and deployment of phenotypic assay and profiling activities to drug projects across all therapeutic areas at AstraZeneca. The High Content Biology group has responsibility for the development and deployment of the company’s high-content imaging platform. Current research interests include the development and application of array-based CRISPR screening and the deployment of advanced cell models and imaging & analytics for target identification, validation and lead optimisation. Bev has worked in the pharmaceutical industry for 13 years with previous roles at AstraZeneca and Pfizer. Bev holds an MA (Natural Sciences) from Cambridge University and a PhD in Molecular Virology from the MRC Virology Unit, Glasgow University.
|
|
|
